Acacia pockets £16m from partial sale of former Woodford Oxford Nanopore stake
Share sale combined with value of US investor’s remaining stake represents a 78% uplift on biotech firm’s last valuation
Oxford Nanopore
-
-
Schroders trust offloads 10% of its Oxford Nanopore holding at biotech firm’s IPO
Oxford Nanopore debuted at a price of 425p per share, netting SUPP £11m
-
Schroders trust welcomes Oxford Nanopore listing but expects to sell down 3.7% stake
Oxford Nanopore represented 21.8% of SUPP’s net asset value on 31 March
-
Execs at Woodford darling Oxford Nanopore set for bumper £160m payday
DNA sequencing unicorn reported a £73m pre-tax loss in 2020 despite revenue boost from government contracts for Covid tests
-
M&G eyes up pre-IPO market by pumping £35m into Woodford favourite Oxford Nanopore
University of Oxford spin-out makes up chunky weighting of Neil Woodford’s comeback fund
-
Former Woodford holding sees gains boosted by Oxford Nanopore success
DNA sequencing start-up among bundle of stocks sold to Acacia Research in June last year
-
Former Woodford biotech stock on the frontlines of Covid raises £84m
LF Equity Income has already ditched the unquoted company but Schroders trust set to benefit
-
Invesco tapped by Tencent for Mark Barnett’s old stake in Oxford Nanopore
Gene sequencing firm was worst-performing stock in Invesco High Income in Q1
-
Unlisted Woodford darling receives £50m injection
California pharma giant invests in Oxford Nanopore
